Ligand profile
NKV
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0978 — NAD(P)(+) transhydrogenase (AB-specific), alpha subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
NKV- PDB
6o7f- UniProt (similar protein)
P9WQB1- Target protein
- VK055_0978
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 142.6
- −1 ≤ LogP ≤ 5 -0.97
- MW ≤ 500 Da 337.3
- LogP ≤ 5 -0.97
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 142.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)C(=O)Nc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OCC(C)C(=O)Nc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
InChI=1S/C14H19N5O5/c1-6(2)13(23)18-11-8-12(16-4-15-11)19(5-17-8)14-10(22)9(21)7(3-20)24-14/h4-7,9-10,14,20-22H,3H2,1-2H3,(H,15,16,18,23)/t7-,9-,10-,14-/m1/s1InChI=1S/C14H19N5O5/c1-6(2)13(23)18-11-8-12(16-4-15-11)19(5-17-8)14-10(22)9(21)7(3-20)24-14/h4-7,9-10,14,20-22H,3H2,1-2H3,(H,15,16,18,23)/t7-,9-,10-,14-/m1/s1
RSLAEWMJDPSZPS-AKAIJSEGSA-NRSLAEWMJDPSZPS-AKAIJSEGSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01262
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand NKV →
- PDB RCSB structure 6o7f →
- UniProt UniProt P9WQB1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “NKV”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0978.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).